Genomatica (GENO) Files $100M IPO
Tweet
Share
E-mail
Genomatica, Inc. (Nasdaq: GENO), filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $100 million. Genomatica plans to list on the Nasdaq Global Market under the ticker "GENO."
The offering is being made through Morgan Stanley, J.P. Morgan, Jefferies, Piper Jaffray, and Raymond James.
Genomatica is a technology leader for the global chemical industry which delivers new, transformative manufacturing processes that enable its partners to produce intermediate and basic chemicals from renewable feedstocks.
The offering is being made through Morgan Stanley, J.P. Morgan, Jefferies, Piper Jaffray, and Raymond James.
Genomatica is a technology leader for the global chemical industry which delivers new, transformative manufacturing processes that enable its partners to produce intermediate and basic chemicals from renewable feedstocks.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quantinuum closes $1.68 billion IPO at $60 per share
- Solidion Technology raises $35 million in private placement above market
- Jade Biosciences completes $172.5 million stock offering
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray, JPMorgan, Raymond James, Morgan Stanley, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
